Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06307431 |
|---|---|
| Brief Title: | A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) |
| First Submitted : | March 6, 2024 |
| First Submitted that Met QC Criteria : | March 6, 2024 |
| First Posted : | March 12, 2024 |
| Last Update Submitted that Met QC Criteria : | May 9, 2024 |
| Last Update Posted : | May 10, 2024 |